Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 2
1995 1
1996 1
1998 2
2010 1
2011 2
2012 2
2013 4
2014 2
2015 4
2016 10
2017 13
2018 11
2019 10
2020 11
2021 9
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson A, Tomasini P, Souquet-Bressand M, Brandone N, Boucekine M, Grangeon M, Chaleat S, Khobta N, Milia J, Mhanna L, Greillier L, Biemar J, Nanni I, Ouafik L, Garcia S, Mazières J, Barlesi F, Mascaux C. Jeanson A, et al. Among authors: tomasini p. J Thorac Oncol. 2019 Jun;14(6):1095-1101. doi: 10.1016/j.jtho.2019.01.011. Epub 2019 Feb 6. J Thorac Oncol. 2019. PMID: 30738221 Free article.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, Pérol M, Campana M, Gautschi O, Früh M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Leccia MT, Jaffro M, Collot S, Prévot G, Milia J, Mazieres J. Delaunay M, et al. Among authors: tomasini p. Eur Respir J. 2017 Aug 10;50(2):1700050. doi: 10.1183/13993003.00050-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28798088 Free article. Clinical Trial.
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer.
Tomasini P, Walia P, Labbe C, Jao K, Leighl NB. Tomasini P, et al. Oncologist. 2016 Dec;21(12):1450-1460. doi: 10.1634/theoncologist.2015-0084. Epub 2016 Nov 2. Oncologist. 2016. PMID: 27807303 Free PMC article. Review.
Solitary cystic mediastinal lymphangioma.
Khobta N, Tomasini P, Trousse D, Maldonado F, Chanez P, Astoul P. Khobta N, et al. Among authors: tomasini p. Eur Respir Rev. 2013 Mar 1;22(127):91-3. doi: 10.1183/09059180.00002212. Eur Respir Rev. 2013. PMID: 23457171 Free article. Review. No abstract available.
Immune Oncology Biomarkers in Lung Cancer: an Overview.
Travert C, Barlesi F, Greillier L, Tomasini P. Travert C, et al. Among authors: tomasini p. Curr Oncol Rep. 2020 Aug 15;22(11):107. doi: 10.1007/s11912-020-00970-3. Curr Oncol Rep. 2020. PMID: 32803433 Review.
Personalised medicine for nonsmall cell lung cancer.
Mascaux C, Tomasini P, Greillier L, Barlesi F. Mascaux C, et al. Among authors: tomasini p. Eur Respir Rev. 2017 Nov 15;26(146):170066. doi: 10.1183/16000617.0066-2017. Print 2017 Dec 31. Eur Respir Rev. 2017. PMID: 29141962 Free article. Review.
Necitumumab for non-small cell lung cancer.
Greillier L, Tomasini P, Barlesi F. Greillier L, et al. Among authors: tomasini p. Expert Opin Biol Ther. 2015;15(8):1231-9. doi: 10.1517/14712598.2015.1055243. Epub 2015 Jun 8. Expert Opin Biol Ther. 2015. PMID: 26051700 Review.
86 results